Ardelyx ARDX
NASDAQ ARDX
$3.39 -0.02 (-0.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ardelyx (ARDX) EBITDA Margin (2013 - 2026)

Updated

Ardelyx (ARDX) reported EBITDA Margin of -9.78% for Q2 2026, up 4.31 percentage points from -14.09% a year earlier and up 23.96 percentage points from the prior quarter.

Analysis

Ardelyx (ARDX) EBITDA Margin (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ardelyx's EBITDA Margin came in at -7.12%, up 2.74 percentage points year-over-year; for FY2025, it came in at -9.31%, down 1.55 percentage points from FY2024.

  • EBITDA Margin has a five-year change of +1152.04 percentage points (FY2020 to FY2025).
  • By year, EBITDA Margin came in at -7.76% in FY2024 (+42.04 pp), -49.80% in FY2023 (+70.24 pp), -120.05% in FY2022 (+1378.41 pp) and -1498.45% in FY2021 (-337.10 pp).
  • Five-year quarterly EBITDA Margin spans a low of -5832.69% in Q1 2022 and a high of 27.77% in Q4 2022.
  • Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +12.95 percentage points.
  • The high point for year-over-year EBITDA Margin in five years was Q1 2023 (a gain of 5603.41 percentage points); the low point was Q1 2022 (a drop of 5354.02 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -33.74% (Q1 2026), 4.81% (Q4 2025) and 5.05% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Ardelyx 849.59 Mn -177.71 Mn 115.12 Mn -9.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.78%
Mar 31, 2026 -33.74%
Dec 31, 2025 4.81%
Sep 30, 2025 5.05%
Jun 30, 2025 -14.09%
Mar 31, 2025 -48.23%
Dec 31, 2024 7.44%
Sep 30, 2024 2.83%
Jun 30, 2024 -17.84%
Mar 31, 2024 -52.68%
Dec 31, 2023 -80.39%
Sep 30, 2023 13.64%
Jun 30, 2023 -71.56%
Mar 31, 2023 -229.28%
Dec 31, 2022 27.77%
Sep 30, 2022 -433.23%
Jun 30, 2022 -1,024.62%
Mar 31, 2022 -5,832.69%
Dec 31, 2021 -3,375.12%
Sep 30, 2021 -3,557.46%
API Access

Ardelyx EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARDX&period=max&api_key=YOUR_API_KEY